Immunovaccine preclinical data

In 4 cynomolgus monkeys, 2 doses of ImmunoVaccine’s DepoVax-formulated Ebola vaccine given at study start and on day 56 led to a 100% survival rate against a lethal challenge with the wild-type Zaire ...